Ohio Country Journal In 2017, as I was preparing for the board exam for the College of Veterinary Preventive Medicine, I spent long days buried in textbooks and long evenings in small-group discussions about hypothetical disease outbreaks. These tabletop scenarios covered everything from foot-and-mouth disease to zoonotic threats, and one in particular still sticks with me: a SARS-like coronavirus spreading rapidly across the globe. Our group debated control measures, tracing the possible path of infection, and brainstorming how to slow it. We quickly ran into a grim reality: limiting human movement enough to meaningfully contain such a disease would be extremely difficult. Our best hope, we concluded, would be the rapid development of an effective vaccine.
At the time, it was just an exercise, but within a few short years, that “what if” became a “right now,” as COVID-19 unfolded in real life and tested the world’s ability to respond. Now, with the highly pathogenic avian influenza (H5N1) outbreak in dairy cattle, we are facing a different kind of challenge, one that is exposing specific weaknesses in how our industry handles novel disease threats.
Fair Use Notice
UNMC Global Center for Health Security staff curate publicly available news and information for educational and informational purposes. Brief excerpts of published articles may be displayed under principles of Fair Use, with credit and links provided to the source publications. All copyrights remain the property of their respective owners.